Bloodwork question about GHK-Cu. Baseline, four months in, and the numbers moved in a direction I did not expect.
The animal data is stronger than the human data and the human data is not nothing, it is just small.
What the peptide class does pharmacologically does not require the subjective effect to be large to be real.
Sample size, blinding, and who paid for it. Those three questions kill most of the confidence in most of these threads.
Vial content, sterility and reconstitution are three separate questions and the certificate answers about one of them.
The interesting question is not whether it works but for whom and at what cost.
Baseline first. Without a baseline the after picture is decoration. Not on GHK-Cu but the pattern is familiar.
Log dose, time and sleep. Ten seconds a day and it turns the anecdote into something you can look at.
Baseline first.
Stupid question: how do you know whether what is in the vial matches the label at all? Same for me with GHK-Cu, unfortunately.
Sleep, food, or the compound? Yes.
Baseline first.
Baseline first.
Same here.
What is the first thing you would read if you were starting from zero?